The regulation of the endothelial barrier in blood vessels is a coordinated signaling process that controls the exchange of oxygen and nutrients with the surrounding tissues. Dysregulation of barrier integrity or function is implicated in a range of pathologies, including metabolic disorders such as diabetes (affecting 8.3% of the US population) and cardiovascular disorders such as atherosclerosis (affecting 25% of the US population). Regulation of the barrier is controlled by small gaseous reactive signaling molecules (e.g. nitric oxide and superoxide) that have proven challenging to detect and quantify with adequate selectivity and sensitivity in cells and more importantly in complex tissues and living animals. Imaging has provided significant insight into regulation of the barrier and related physiologic changes that correlate with disease and disease treatment. Yet imaging of signaling molecules associated with the barrier continues to pose significant challenges because the currently available fluorescent biosensors are not sufficiently specific or sensitive to directly report the concentrations and locations of the analytes. Both dye based fluorescent probes and fluorescent protein sensors suffer from limitations that prevent simultaneous correlative measurements of molecular signaling and vascular physiology. In this proposal, we develop a new class of fluorescent molecular biosensor dyes that combine the advantages of indicator dyes with the specificity of genetic encoding. By using tissue specific expression and genetically encoded subcellular targeting, these new biosensors will allow detection of Ca(II), reactive oxygen species (ROS), and reactive nitrogen species (RNS) in specific cells, at specific subcellular locations. These novel targeted fluorescent biosensors are constructed by linking together a sensitive optical sensor of Ca, ROS, or RNS with a fluorescent signaling moiety (FRET acceptor) that is activated upon binding to a genetically encoded receptor, called a fluorogen activating protein (FAP). FAP-bound sensor is able to report (fluorescence signal) the physiology of the sensing at the site of interest. Any biosensors that are not bound to the FAP target are incapable of producing a fluorescence signal and there is no background or non-specific fluorescence to complicate images or analysis of the data. The targeted biosensor dyes will be optimized to work in both cultured endothelial cells and living zebrafish. Transgenic zebrafish will be generated that express the FAP at subcellular locations in specific cells using tissue specific Cre-recombinase expression. We will use these sensors in zebrafish to assess the correlation between Ca(II), ROS and NO signaling, blood flow and barrier function. This project is a close collaboration of three Principal Investigators with distinct expertise at Carnege Mellon University and University of Pittsburgh. Dr. Bruchez is an expert on the development of multichromophore structures for biological detection, and designed the hybrid indicators for biosensing using the fluorogen activating proteins;Dr. St. Croix is an expert on endothelial cell biology RNS/ROS signaling and regulation of endothelial function and more specifically the imaging of endothelium in vitro and in vivo. Dr. Waggoner is an expert in the design of environmentally sensitive dyes, and original developer of the fluorogen activating protein technology.
Endothelial dysfunction encompasses any defect in endothelial morphology or function that has deleterious consequences to the underlying tissue. As such, the phenomenon has been associated with a host of vasculopathologies, including atherosclerosis, hypertension, coronary disease, diabetes, sepsis, heart and renal failure. In this proposal, we develop new tools that will allow us to correlate subcellular molecular signaling pathways with these physical processes in living zebrafish embryos, as a model for the human circulatory system. Establishing these empirical connections will allow us to test potential drug targets and therapeutic strategies for managing these disorders in a functionally relevant organism.
|Perkins, Lydia A; Fisher, Gregory W; Naganbabu, Matharishwan et al. (2018) High-Content Surface and Total Expression siRNA Kinase Library Screen with VX-809 Treatment Reveals Kinase Targets that Enhance F508del-CFTR Rescue. Mol Pharm 15:759-767|
|Perkins, Lydia A; Yan, Qi; Schmidt, Brigitte F et al. (2018) Genetically Targeted Ratiometric and Activated pH Indicator Complexes (TRApHIC) for Receptor Trafficking. Biochemistry 57:861-871|
|Wang, Yi; Ballou, Byron; Schmidt, Brigitte F et al. (2017) Affibody-targeted fluorogen activating protein for in vivo tumor imaging. Chem Commun (Camb) 53:2001-2004|
|Mao, Gaowei; Qu, Feng; St Croix, Claudette M et al. (2016) Mitochondrial Redox Opto-Lipidomics Reveals Mono-Oxygenated Cardiolipins as Pro-Apoptotic Death Signals. ACS Chem Biol 11:530-40|
|Naganbabu, Matharishwan; Perkins, Lydia A; Wang, Yi et al. (2016) Multiexcitation Fluorogenic Labeling of Surface, Intracellular, and Total Protein Pools in Living Cells. Bioconjug Chem 27:1525-31|
|He, Jianjun; Wang, Yi; Missinato, Maria A et al. (2016) A genetically targetable near-infrared photosensitizer. Nat Methods 13:263-8|
|Larsen, Mads Breum; Hu, Jennifer; Frizzell, Raymond A et al. (2016) Simple image-based no-wash method for quantitative detection of surface expressed CFTR. Methods 96:40-45|
|Wallace, Callen T; St Croix, Claudette M; Watkins, Simon C (2015) Data management and archiving in a large microscopy-and-imaging, multi-user facility: Problems and solutions. Mol Reprod Dev 82:630-4|
|Telmer, Cheryl A; Verma, Richa; Teng, Haibing et al. (2015) Rapid, specific, no-wash, far-red fluorogen activation in subcellular compartments by targeted fluorogen activating proteins. ACS Chem Biol 10:1239-46|
|Khoo, Nicholas K H; Cantu-Medellin, Nadiezhda; St Croix, Claudette et al. (2015) In Vivo Immuno-Spin Trapping: Imaging the Footprints of Oxidative Stress. Curr Protoc Cytom 74:12.42.1-11|
Showing the most recent 10 out of 14 publications